Asset Publisher

Medical Policies

Our draft medical policies and final medical policies are displayed on this site. Medical policies are based on the most current medical research available at the time of the policy development.

Policies are written to cover a given condition for the majority of people. Each individual's unique clinical circumstances may be considered in light of current scientific literature. Medical policies are based on constantly changing medical science and the Plan reserves the right to review and update our policies as necessary.

We encourage practicing physicians to provide input related to developing, adopting and reviewing criteria for medical policy. Any licensed practitioner is welcome to provide comments, suggestions or concerns. Our internal policy committee will review and take your comments into consideration. For medical policy feedback, email comments to mpc@credenceblue.com.

Search Medical Policies

Use the search function above to locate policies by name, number or keyword.

Browse Medical Policies

Use the navigation on the left to view our draft or final medical policies.

Medical Policies Disclaimer

Benefits are payable in cases of medical necessity and only if services or supplies are not investigational.

Policies are intended to be used for some or all of the following purposes in Credence's administration of plans: (i) adjudication of claims (including pre-admission certification, pre-determinations and pre-procedure review); (ii) retrospective review of provider claims; (iii) provider audits; (iv) fraud and abuse investigations; and (v) other programs instituted from time to time to determine the appropriateness of payments under plans.

The following Association Technology Evaluation Criteria must be met for a service/supply to be considered for coverage:

  1. The technology or treatment must have final approval from the appropriate government regulatory bodies;
  2. The scientific evidence must permit conclusions concerning the effects of the technology on health outcomes;
  3. The technology must improve the net health outcome;
  4. The technology must be as beneficial as any established alternatives;
  5. The improvement must be attainable outside the investigational setting.